Related Experiment Video
Updated: Jun 7, 2025

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
Phage-Derived Endolysins Against Resistant Staphylococcus spp.: A Review of Features, Antibacterial Activities, and
Mina Golban1, Javad Charostad1, Hossein Kazemian2
1Department of Microbiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Abstract:
Antimicrobial resistance is a significant global public health issue, and the dissemination of antibiotic resistance in Gram-positive bacterial pathogens has significantly increased morbidity, mortality rates, and healthcare costs. Among them, Staphylococcus, especially methicillin-resistant Staphylococcus aureus (MRSA), causes a wide range of diseases due to its diverse pathogenic factors and infection strategies. These bacteria also present significant issues in veterinary medicine and food safety. Effectively managing staphylococci-related problems necessitates a concerted effort to implement preventive measures, rapidly detect the pathogen, and develop new and safe antimicrobial therapies. In recent years, there has been growing interest in using endolysins to combat bacterial infections. These enzymes, which are also referred to as lysins, are a unique class of hydrolytic enzymes synthesized by double-stranded DNA bacteriophages. They possess glycosidase, lytic transglycosylase, amidase, and endopeptidase activities, effectively destroying the peptidoglycan layer and resulting in bacterial lysis. This unique property makes endolysins powerful antimicrobial agents, particularly against Gram-positive organisms with more accessible peptidoglycan layers. Therefore, considering the potential benefits of endolysins compared to conventional antibiotics, we have endeavored to gather and review the characteristics and uses of endolysins derived from staphylococcal bacteriophages, as well as their antibacterial effectiveness against Staphylococcus spp. based on conducted experiments and trials.
Insights
Endolysins, derived from bacteriophages, show promise as novel antimicrobial agents against Staphylococcus species, including MRSA. These enzymes offer a potential alternative to conventional antibiotics for combating rising antimicrobial resistance.
Area of Science:
- Microbiology and Infectious Diseases
- Biotechnology and Enzyme Engineering
Background:
- Antimicrobial resistance in Gram-positive bacteria, particularly Staphylococcus aureus (MRSA), poses a significant global health threat, increasing morbidity, mortality, and healthcare expenses.
- Staphylococcal infections present challenges in human and veterinary medicine, necessitating novel therapeutic strategies beyond traditional antibiotics.
- Endolysins, bacteriophage-derived hydrolytic enzymes, are emerging as potent antimicrobial agents due to their ability to degrade bacterial peptidoglycan.
Purpose of the Study:
- To review the characteristics and applications of endolysins derived from staphylococcal bacteriophages.
- To evaluate the antibacterial efficacy of these endolysins against various Staphylococcus species.
- To explore endolysins as a potential alternative to conventional antibiotics for treating staphylococcal infections.
Main Methods:
- Literature review and analysis of existing experimental data on staphylococcal endolysins.
- Examination of endolysin enzymatic activities (glycosidase, amidase, etc.) targeting the bacterial peptidoglycan layer.
- Assessment of antibacterial effectiveness through in vitro and in vivo studies cited in the literature.
Main Results:
- Endolysins exhibit potent lytic activity against Staphylococcus spp., including antibiotic-resistant strains like MRSA.
- The specific enzymatic activities of endolysins facilitate rapid bacterial cell lysis by degrading the peptidoglycan structure.
- Studies indicate promising antibacterial effectiveness of staphylococcal endolysins, suggesting their potential as therapeutic agents.
Conclusions:
- Endolysins represent a promising class of antimicrobial agents with significant potential for combating staphylococcal infections.
- Their unique mechanism of action and effectiveness against resistant strains offer a viable alternative to conventional antibiotics.
- Further research and development of endolysins are warranted for clinical and veterinary applications against Staphylococcus spp.
Related Concept Videos
Lytic Cycle of Bacteriophages
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Biological Methods for Microbial Control
Gene Regulation in Microbial Communities: Quorum Sensing
Lysogenic Cycle of Bacteriophages
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

